EFDID: 303756EFD: View Filing

Issuer: Kalytera Therapeutics, Inc. (0001639643) - D

Accession: 0001639643-19-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    Kalytera Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    BRITISH COLUMBIA, CANADA
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    4040 CIVIC CENTER DRIVE, SUITE 200
    SAN RAFAEL, CA 94903
  • Persons:
    Related Persons 5
    Robert Farrell
    Executive Officer, Director
    Ronald Erickson
    Director
    Gary Leong
    Director
    Jeff Paley
    Director
    Victoria Rudman
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    01/29/2019
  • First Sale Date:
    01/15/2019
  • Offering Amount:
    $1,050,000
  • Amount Sold:
    $450,000
  • Amount Remaining:
    $600,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    The estimated amounts are based on CAD$1.3454/USD$1.00 exchange rate. The Total Offering Amount includes the aggregate exercise price of USD$600,000 in respect of unexercised warrants issued as part of the offering.
EFD: Current State Notices

Notices found in EFD

Filed:NJ
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Alere Financial Partners, a division of Cova Capital Partners LLC 109761 None None NJ, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Kalytera Therapeutics, Inc./s/ Robert FarrellRobert FarrellPresident, CEO and Director2019-01-29